These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 16476304

  • 1. [Cutaneous marginal zone B-cell lymphoma treated with rituximab].
    Pedraz J, Delgado Y, Aragüés M, Fraga J, García-Díez A, Fernández-Herrera J.
    Actas Dermosifiliogr; 2005 Nov; 96(9):593-7. PubMed ID: 16476304
    [Abstract] [Full Text] [Related]

  • 2. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
    Gellrich S, Muche JM, Wilks A, Jasch KC, Voit C, Fischer T, Audring H, Sterry W.
    Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
    [Abstract] [Full Text] [Related]

  • 3. Primary cutaneous B-cell lymphomas.
    Kempf W, Denisjuk N, Kerl K, Cozzio A, Sander C.
    J Dtsch Dermatol Ges; 2012 Jan; 10(1):12-22; quiz 23. PubMed ID: 22212142
    [Abstract] [Full Text] [Related]

  • 4. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma.
    Peñate Y, Hernández-Machín B, Pérez-Méndez LI, Santiago F, Rosales B, Servitje O, Estrach T, Fernández-Guarino M, Calzado L, Acebo E, Gallardo F, Salar A, Izu R, Ortiz-Romero PL, Pujol RM, Fernández-de-Misa R.
    Br J Dermatol; 2012 Jul; 167(1):174-9. PubMed ID: 22356294
    [Abstract] [Full Text] [Related]

  • 5. Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature.
    Gitelson E, Al-Saleem T, Millenson M, Lessin S, Smith MR.
    Leuk Lymphoma; 2006 Sep; 47(9):1902-7. PubMed ID: 17065004
    [Abstract] [Full Text] [Related]

  • 6. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
    Viguier M, Bachelez H, Brice P, Rivet J, Dubertret L.
    Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
    [Abstract] [Full Text] [Related]

  • 7. Rituximab in cutaneous B-cell lymphoma: a report of two cases.
    Sabroe RA, Child FJ, Woolford AJ, Spittle MF, Russell-Jones R.
    Br J Dermatol; 2000 Jul; 143(1):157-61. PubMed ID: 10886152
    [Abstract] [Full Text] [Related]

  • 8. Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review.
    Fernández-Guarino M, Ortiz-Romero PL, Fernández-Misa R, Montalbán C.
    Actas Dermosifiliogr; 2014 Jun; 105(5):438-45. PubMed ID: 23540593
    [Abstract] [Full Text] [Related]

  • 9. Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases.
    Kennedy GA, Blum R, McCormack C, Prince HM.
    Australas J Dermatol; 2004 Feb; 45(1):34-7. PubMed ID: 14961906
    [Abstract] [Full Text] [Related]

  • 10. Rituximab-related urticarial reaction in a patient treated for primary cutaneous B-cell lymphoma.
    Errante D, Bernardi D, Bianco A, De Nardi S, Salvagno L.
    Ann Oncol; 2006 Nov; 17(11):1720-1. PubMed ID: 16731537
    [No Abstract] [Full Text] [Related]

  • 11. Primary cutaneous large B-cell lymphoma of the legs: a distinct clinical pathologic entity treated with CD20 monoclonal antibody (rituximab).
    Aboulafia DM.
    Am J Clin Oncol; 2001 Jun; 24(3):237-40. PubMed ID: 11404492
    [Abstract] [Full Text] [Related]

  • 12. Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab.
    Park MY, Jung HJ, Park JE, Kim YC.
    Eur J Dermatol; 2010 Jun; 20(4):533-4. PubMed ID: 20542839
    [No Abstract] [Full Text] [Related]

  • 13. Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.
    Brunet-Possenti F, Franck N, Tamburini J, Jacobelli S, Avril MF, Dupin N.
    Dermatology; 2011 Jun; 223(3):200-2. PubMed ID: 21986026
    [Abstract] [Full Text] [Related]

  • 14. Regression of cutaneous intravascular lymphoma with rituximab.
    Han K, Haley JC, Carlson K, Pinter-Brown L, Soriano T.
    Cutis; 2003 Aug; 72(2):137-40. PubMed ID: 12953938
    [Abstract] [Full Text] [Related]

  • 15. Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients.
    Valencak J, Weihsengruber F, Rappersberger K, Trautinger F, Chott A, Streubel B, Muellauer L, Der-Petrossian M, Jonak C, Binder M, Raderer M.
    Ann Oncol; 2009 Feb; 20(2):326-30. PubMed ID: 18836086
    [Abstract] [Full Text] [Related]

  • 16. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
    Kyrtsonis MC, Siakantaris MP, Kalpadakis C, Dimopoulou MN, Vassilakopoulos TP, Kontopidou FN, Antoniou C, Korkolopoulou P, Panayiotidis P, Pangalis GA.
    Eur J Haematol; 2006 Oct; 77(4):300-3. PubMed ID: 16856917
    [Abstract] [Full Text] [Related]

  • 17. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K, Prins C, Saurat JH, French LE.
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B-cell lymphomas.
    Brandenburg A, Humme D, Terhorst D, Gellrich S, Sterry W, Beyer M.
    Br J Dermatol; 2013 Nov; 169(5):1126-32. PubMed ID: 23796422
    [Abstract] [Full Text] [Related]

  • 19. Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody.
    Soda R, Costanzo A, Cantonetti M, Orlandi A, Bianchi L, Chimenti S.
    Acta Derm Venereol; 2001 Nov; 81(3):207-8. PubMed ID: 11558880
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-CD20 antibodies in primary cutaneous B-cell lymphoma. Initial results in dermatologic patients].
    Gellrich S, Muche JM, Pelzer K, Audring H, Sterry W.
    Hautarzt; 2001 Mar; 52(3):205-10. PubMed ID: 11284065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.